Search
buprenorphine/naloxone (Bunavail, Suboxone)
Combination of buprenorphine plus naloxone.
DEA-controlled substance: class 5.
Certification & special DEA # required for prescription.
Prescribers must get a Drug Addiction Treatment Act (DATA 2000) waiver to become certified to prescribe Suboxone for office-based treatment of opioid dependence. This involves completion of an approved eight hour CME course & notification of the government of the intent to use Suboxone or Subutex to treat opioid-dependent patients. Pharmacists can check if a prescriber has a DATA 2000 waiver because the DEA number will always start with an 'X'. For prescribers to obtain a DATA 2000 waiver see [2]
Indications:
- treatment of opiate abuse & opioid dependence (opioid maintenance therapy)
Dosage:
- 2 mg & 8 mg (of buprenorphine) sublingual
- sublingual film* can be cut for dose tapering [4]
- mucoadhesive buccal film (Bunavail)
* requires opiate washout so as not to precipitate withdrawal [8]
* FDA has approved first generic versions of sublingual film [7]
General
pharmacologic combination
References
- Prescriber's Letter 9(11):65 2002
- Drug Addiction Treatment Act (DATA 2000) waiver
http://www.suboxone.com/hcp/certification/
- Wikipedia: Buprenorphine
http://en.wikipedia.org/wiki/Buprenorphine
- Prescriber's Letter 18(1): 2011
New Formulation: Suboxone Sublingual Film
Detail-Document#: 270109
(subscription needed) http://www.prescribersletter.com
- biodelivery. June 6m 2014
First and Only FDA-Approved Buccal Film Formulation of
Buprenorphine and Naloxone to Compete in the $1.7 Billion and
Growing U.S. Opioid Dependence Market.
http://bdsi.investorroom.com/2014-06-06-BioDelivery-Sciences-Receives-FDA-Approval-for-BUNAVAIL-buprenorphine-and-naloxone-Buccal-Film-for-the-Maintenance-Treatment-of-Opioid-Dependence
- Brooks M
FDA OKs Bunavail for Induction of Opioid Addiction Treatment.
Medscape - May 02, 2017.
http://www.medscape.com/viewarticle/879399
- Brooks M
FDA Clears First Generic Versions of Suboxone Sublingual Film
Medscape - Jun 14, 2018.
https://www.medscape.com/viewarticle/898114
- FDA News Release. June 14, 2018
FDA approves first generic versions of Suboxone sublingual film,
which may increase access to treatment for opioid dependence.
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm610807.htm
- VA Southern Oregon Rehabilitation Center and Clinics SORCC
8495 Crater Lake Highway
White City, OR 97503
Components
buprenorphine (Buprenex, Subutex, Temgesic, Sublocade, Butrans 'professional man's methadone')
naloxone (Narcan, Evzio, ReVive)